Clinical trial
LMWH to Prevent Preeclampsia and Fetal Growth Restriction
NCT00260520 · University of Florence, Other · Terminated
Key facts
| NCT number | NCT00260520 |
|---|---|
| Title | LMWH to Prevent Preeclampsia and Fetal Growth Restriction |
| Official title | Low Molecular Weight Heparin Vs No Treatment in Pregnant Women With Previous Preeclampsia or Fetal Growth Restriction Who Were Heterozygote for Factor V Leiden or Prothrombin Gene G20210A Mutation |
| Lead sponsor | University of Florence, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Preeclampsia |
| Intervention type | Drug |
| Interventions | Dalteparin |
| Start date | Jan 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | Dec 1, 2005 |
| Last update posted | Mar 6, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: